International Standard Serial Number (ISSN)
publication venue for
Excess Mortality and Life-Years Lost in People With Schizophrenia and Other Non-affective Psychoses: An 11-Year Population-Based Cohort Study.
Mortality, Revascularization, and Cardioprotective Pharmacotherapy After Acute Coronary Syndrome in Patients With Psychotic Disorders: A Population-Based Cohort Study.
Early-Stage Negative Symptom Trajectories and Relationships With 13-Year Outcomes in First-Episode Nonaffective Psychosis.
Glutamatergic and Neuronal Dysfunction in Gray and White Matter: A Spectroscopic Imaging Study in a Large Schizophrenia Sample.
Modality-Dependent Impact of Hallucinations on Low-Frequency Fluctuations in Schizophrenia.
A Randomized Comparison of Aripiprazole and Risperidone for the Acute Treatment of First-Episode Schizophrenia and Related Disorders: 3-Month Outcomes.
Relationship of Cognition to Clinical Response in First-Episode Schizophrenia Spectrum Disorders.
Association of a Schizophrenia Risk Variant at the DRD2 Locus With Antipsychotic Treatment Response in First-Episode Psychosis.
Spatial Variance in Resting fMRI Networks of Schizophrenia Patients: An Independent Vector Analysis.
Comparison of SGA oral medications and a long-acting injectable SGA: the PROACTIVE study.
Clinical and functional outcomes after 2 years in the early detection and intervention for the prevention of psychosis multisite effectiveness trial.
Visual hallucinations are associated with hyperconnectivity between the amygdala and visual cortex in people with a diagnosis of schizophrenia.
Patterns of Gray Matter Abnormalities in Schizophrenia Based on an International Mega-analysis.
Studying hallucinations within the NIMH RDoC framework.
. 40 Suppl 4:S295-S304.
Methylation patterns in whole blood correlate with symptoms in schizophrenia patients.
Gender-specific reduction of estrogen-sensitive small RNA, miR-30b, in subjects with schizophrenia.
Global white matter abnormalities in schizophrenia: a multisite diffusion tensor imaging study.
Catatonia in the DSM--shall we move or not?